- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Hierarchy of evidence.
Displaying page 1 of 1.
EudraCT Number: 2019-001153-10 | Sponsor Protocol Number: X4P-001-103 | Start Date*: 2020-02-05 | |||||||||||
Sponsor Name:X4 Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients with WHIM Syndrome with Open-Label Extension | |||||||||||||
Medical condition: WHIM Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DK (Trial now transitioned) HU (Completed) ES (Ongoing) PL (Completed) AT (Completed) DE (Completed) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001967-11 | Sponsor Protocol Number: PBD01071 | Start Date*: 2015-02-05 | ||||||||||||||||
Sponsor Name:Probiodrug AG | ||||||||||||||||||
Full Title: A Phase 2A Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Safety and Tolerability Trial of PQ912 in Subjects with early Alzheimer's Disease | ||||||||||||||||||
Medical condition: Early Stage Alzheimer's Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) FI (Completed) DE (Completed) SE (Completed) BE (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-003549-16 | Sponsor Protocol Number: Tulir 03/01 | Start Date*: 2006-03-08 | |||||||||||
Sponsor Name:NeuroBiotec GmbH | |||||||||||||
Full Title: Transdermal Lisuride: A double-blind, randomized, active- and placebo-controlled multi-centre phase III efficacy trial for the treatment of patients with Restless Legs Syndrome (RLS) | |||||||||||||
Medical condition: Idiopathic and Uremic Restless Legs Syndrome (RLS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002500-24 | Sponsor Protocol Number: AOSD.2014.001 | Start Date*: 2015-02-19 | |||||||||||
Sponsor Name:AB2 Bio Ltd. | |||||||||||||
Full Title: Open-label, multicenter, dose-escalating phase II study to investigate the safety, tolerability, and early signs of efficacy of subcutaneous administrations of Tadekinig alfa (IL-18BP) in patients ... | |||||||||||||
Medical condition: Adult -onset Still’s Disease (AoSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
